Safety updates
A safety update gives practical information relating to the safety of a medicine or medical device (therapeutic product), including emerging safety issues. These updates are provided for health professionals.
The medicine safety updates replaced the Australian Adverse Drug Reactions Bulletin in 2010.
Find archived copies for 1995 to 2009 at the National Library of Australia in Trove Australian Adverse Drug Reactions Bulletin archive (external site).
You can search the Article index from 1982 to 2009
Medicine safety updates
Our Medicine safety update (MSU) articles provide health professionals with practical information and advice on medicine safety, including emerging safety issues. We publish these articles as the safety issues occur.
As well as these detailed articles, we publish a monthly list of Product Information safety updates. This summarises significant changes relating to medicine safety for health professionals (see links to the latest safety updates below).
Anyone can subscribe and receive email notifications when new articles are published.
Medical devices safety updates
Medical Devices Safety Update (MDSU) provides health professionals with practical information and advice on medical device safety and information about emerging safety issues.
The articles provide information on adverse event reporting and how health professionals can contribute to safety monitoring in Australia.
Safety update articles are published as relevant topics arise.
Health professionals and interested persons can subscribe and receive email notifications when new articles are published.
Latest Safety updates
-
Information for health professionals about medicines with safety related updates to their Product Information.
-
Oral preparations containing more than 50 mg but not more than 200 mg per recommended daily dose of vitamin B6 will be rescheduled as Pharmacist Only Medicines from 1 June 2027.
-
Information for health professionals about medicines with safety related updates to their Product Information.
-
Information for health professionals about medicines with safety related updates to their Product Information.
-
Information for health professionals about medicines with safety related updates to their Product Information.
-
Our investigation into the potential for reduced effectiveness of oral contraception during initiation or dose escalations with Mounjaro (tirzepatide) has found that this association could not be ruled out.